Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Kimmoisa Oy
OY
Active
Y-tunnus 2836168-4
Kanneltie 13A, 01260
Vantaa
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2017 · 9 years old
1 employees
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Kimmoisa Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
1M
1M
1M
1M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
EUR millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Income statement
EUR thousands
Item
2020
2021
2022
2023
2024
Revenue
647
313
233
168
231
Staff expenses
−3
−10
−33
−24
−52
EBITDA
248
38
12
8
12
Depreciation & amort.
−4
−4
−10
−6
−5
EBIT
244
34
2
2
7
Net financials
−10
−1
−1
−0
−7
Profit before tax
234
33
1
2
−1
Tax
48
7
1
1
0
Net profit
187
27
1
1
−1
Balance sheet
EUR thousands
Item
2020
2021
2022
2023
2024
Total assets
425
277
273
264
258
Equity
208
218
201
186
185
Long-term debt
34
—
22
22
22
Short-term debt
184
59
50
56
51
Total debt
217
59
72
78
73
Financial ratios
5-year trend
EBITDA-margin
5.0%
This company
15.8%
Market median
-68% vs market
2020
2024
Soliditetsgrad
71.6%
This company
38.2%
Market median
+87% vs market
2020
2024
Egenkapitalforrentning
-0.5%
This company
18.4%
Market median
-103% vs market
2020
2024
Nettoresultatgrad
-0.4%
This company
8.1%
Market median
-105% vs market
2020
2024
Aktivomsætning
0.89×
This company
1.12×
Market median
+21% vs market
2020
2024
Gæld/egenkapital
0.40×
This company
0.62×
Market median
+35% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via PRH / YTJ · Period 2023-11-01 – 2024-10-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2022-11-01 – 2023-10-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2021-11-01 – 2022-10-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2020-11-01 – 2021-10-31
View
PDF
Annual report 2020
Filed via PRH / YTJ · Period 2019-11-01 – 2020-10-31
View
PDF
More on Kimmoisa Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
